Quantum-Si (QSI) Revenue & Revenue Breakdown
Quantum-Si Revenue Highlights
Latest Revenue (Y)
$1.08M
Latest Revenue (Q)
$457.00K
Main Segment (Y)
Product
Main Geography (Y)
Domestic
Quantum-Si Revenue by Period
Quantum-Si Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $1.08M | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Quantum-Si Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $457.00K | 14.25% |
2023-12-31 | $400.00K | 79.37% |
2023-09-30 | $223.00K | 8.78% |
2023-06-30 | $205.00K | -19.29% |
2023-03-31 | $254.00K | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Quantum-Si Revenue Breakdown
Quantum-Si Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 |
---|---|
Product | $1.03M |
Service | $51.00K |
Quarterly Revenue by Product
Product/Service | Dec 23 | Jun 23 | Mar 23 |
---|---|---|---|
Service | $30.00K | $18.00K | $3.00K |
Product | $593.00K | $187.00K | $251.00K |
Quantum-Si Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 |
---|---|
International | $300.00K |
Domestic | $800.00K |
Quarterly Revenue by Country
Country | Dec 23 | Jun 23 |
---|---|---|
Domestic | $698.00K | $102.00K |
Quantum-Si Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
BEAM | Beam Therapeutics | $377.71M | $11.77M |
CRSP | CRISPR Therapeutics | $370.00M | $517.00K |
HRTX | Heron Therapeutics | $127.04M | $46.54M |
ALEC | Alector | $97.06M | $15.89M |
NRIX | Nurix Therapeutics | $76.99M | $12.09M |
NTLA | Intellia Therapeutics | $36.27M | $6.96M |
CRBU | Caribou Biosciences | $34.48M | $3.46M |
HOOK | HOOKIPA Pharma | $20.13M | - |
SEER | Seer | $16.66M | $3.07M |
VERV | Verve Therapeutics | $11.76M | $5.70M |
RNA | Avidity Biosciences | $9.56M | $2.04M |
HCWB | HCW Biologics | $2.84M | $618.85K |
FIXX | Q32 Bio | $1.16M | - |
QSI | Quantum-Si | $1.08M | $457.00K |
MNOV | MediciNova | $1.00M | - |
EDIT | Editas Medicine | - | - |
BDTX | Black Diamond Therapeutics | - | - |
PRME | Prime Medicine | - | - |
ABOS | Acumen Pharmaceuticals | - | - |
PASG | Passage Bio | - | - |
QSI Revenue FAQ
What is Quantum-Si’s yearly revenue?
Quantum-Si's yearly revenue for 2023 was $1.08M, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. QSI's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Quantum-Si’s quarterly revenue?
Quantum-Si's quarterly revenue for Q1 2024 was $457K, a 14.25% increase from the previous quarter (Q4 2023), and a 79.92% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $400K, a 79.37% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). QSI's quarterly revenue for Q3 2023 was $223K, a 8.78% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).
What is Quantum-Si’s revenue growth rate?
Quantum-Si's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.
What are Quantum-Si’s revenue streams?
Quantum-Si's revenue streams in c 23 are Product, and Service. Product generated $1.03M in revenue, accounting 95.29% of the company's total revenue Service generated $51K in revenue, accounting 4.71% of the company's total revenue
What is Quantum-Si’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Quantum-Si was Product. This segment made a revenue of $1.03M, representing 95.29% of the company's total revenue.